<DOC>
	<DOCNO>NCT00241683</DOCNO>
	<brief_summary>To determine whether woman history baby intrauterine growth retardation ( IUGR ) likely risk factor cardiovascular disease versus woman pregnancy complicate IUGR .</brief_summary>
	<brief_title>Fetal Growth Restriction &amp; Maternal Cardiovascular Risk</brief_title>
	<detailed_description>BACKGROUND : Intrauterine growth restriction lead major neonatal morbidity mortality . Moreover , recent birth registry study suggest woman bear IUGR baby may elevate risk cardiovascular disease . DESIGN NARRATIVE : This cohort study test whether exposed woman , previous intrauterine growth restriction ( IUGR ) baby , versus unexposed woman , pregnancy complicate IUGR , elevations marker cardiovascular risk . Exposure define among geographically define cohort singleton baby &lt; 5 % tile weight gestational age , absence pre-pregnancy diabetes. , hypertension , renal disease , hypertension pregnancy ; control singleton &gt; 20 % tile . Four twelve year postpartum , woman assess multiple marker cardiovascular risk , include blood pressure , lipid , adiposity , glucose insulin , homocysteine folate , marker inflammation , marker endothelial function , marker angiogenesis , marker vascular function . Data analysis consist ANOVA ANCOVA analyse compare outcome cardiovascular marker among expose unexposed woman .</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Fetal Growth Retardation</mesh_term>
	<criteria>Inclusion criterion : woman 4 12 year delivery singleton infant woman give birth 1997 2002 MageeWomens Hospital Pittsburgh , Pennsylvania Exclusion criterion : woman preeclampsia woman prepregnancy hypertension woman diabetes woman currently pregnant report prepregnancy chronic condition</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
</DOC>